...
 Why us?  Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

 Author  Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making. Authored and medically reviewed by Dr Farzana Khan.

MD MRCGP DFFP
Was this answer helpful?
Rate Dr Farzana's explanation

Assessment first
Evidence-aware
Safety focused

Women’s Health Clinic FAQ

Can the O-Shot Help with PGAD?

PGAD can be distressing because sensations may be unwanted, intrusive and difficult to explain. It needs sensitive, specialist assessment rather than sexual-enhancement framing.

Direct answer

The O-Shot is not a standard treatment for persistent genital arousal disorder, or PGAD. PGAD can involve unwanted genital sensations, nerve sensitivity, pelvic-floor overactivity, medication effects, spinal or neurological factors and significant distress. PRP should not be offered as a simple solution. A careful specialist assessment is needed first, and urgent advice may be appropriate if symptoms are sudden, severe, associated with numbness or linked to neurological change.

The safest next step is to separate the symptom pattern from the treatment name, then decide whether PRP, another pathway or combined care is more appropriate.

Educational only. Suitability must be confirmed after consultation. Results vary. Not a cure.

Women's Health Clinic consultation for persistent genital arousal disorder symptoms and O-Shot suitability
Consultation-led care

At a glance

These are the key points to understand before considering PRP for persistent genital arousal disorder symptoms.

At a glance

Clinical summary

First step

Clarify the symptom pattern before choosing treatment.

May suit

Selected tissue-related symptoms after assessment.

Evidence status

Evidence is developing; response and protocols vary.

Not a shortcut

Pain, infection, skin disease or surgical concerns need review first.

Important suitability note

New, severe, worsening or unexplained symptoms should be assessed before elective intimate treatment.

Symptoms
PRP
Assessment
Safety
Aftercare




Detailed answer

How PRP may fit into persistent genital arousal disorder symptoms care

The O-Shot should be discussed as one possible assessed option, not as a universal answer for complex intimate symptoms.

Clinical context

PGAD may involve nerve sensitivity, pelvic-floor overactivity, medication changes, spinal factors, anxiety around symptoms and pain. The treatment pathway is usually specialist and multidisciplinary.

Tissue quality
Pain pattern
Pelvic floor
Alternatives

What the O-Shot is

A blood sample is processed to concentrate platelets. The platelet-rich plasma is then injected into selected intimate tissue after consent and numbing.

How it may work

Platelet signalling proteins are involved in repair pathways such as collagen support, blood-vessel formation, hydration and tissue resilience.

What it does not replace

PRP does not replace diagnosis, infection checks, vulval skin assessment, pelvic-floor review, specialist referral or established treatment where needed.

Why symptoms matter

Location, trigger, severity, timing, associated bleeding, discharge, urinary change or numbness can all change the clinical pathway.

What this means in practice

Established options such as moisturisers, lubricants, local hormone discussion, vulval care, scar care, pelvic-floor support or specialist review may be needed before or alongside PRP.

If PRP is suitable, the aim is usually gradual tissue support rather than an instant or certain response. Non-response should lead to reassessment.





Patient safety

Why proper assessment matters

Persistent genital arousal disorder symptoms can have more than one driver, so the page should not collapse the concern into a single treatment claim.

It identifies the cause

The right treatment depends on whether symptoms are linked to tissue change, skin disease, infection, pelvic-floor function, scarring, nerves or hormones.

It protects safety

Bleeding, unusual discharge, fever, severe pain, new numbness or urinary change should be reviewed before elective intimate treatment.

It avoids over-treatment

Some patients need conservative care, medication, pelvic-floor support, specialist review or monitoring rather than PRP first.

It sets expectations

PRP response is gradual and variable. It may support tissue quality, but it cannot promise one predictable outcome.

A careful symptom map comes first

A good consultation asks what has changed, when it happens, where it is felt, what makes it worse and what treatments have already been tried.

That distinction helps decide whether PRP is worth discussing, whether another pathway should come first, or whether combined care is more appropriate.





Considerations

What to consider before booking

Before choosing the O-Shot for persistent genital arousal disorder symptoms, it is important to understand the cause, evidence limits, procedure, aftercare and alternatives.

Consultation priorities

Your clinician should review symptoms, medical history, medication, vulval skin, pain pattern, urinary symptoms, previous treatment and goals before discussing PRP.

History
Examination
Consent
Follow-up

Before treatment

You may need review for infection, abnormal bleeding, vulval skin change, pelvic pain, medication effects, surgery history or menopause-related tissue change.

During the procedure

If PRP is chosen, the appointment usually involves consent, cleansing, blood draw, centrifuge preparation, numbing and targeted injections.

Aftercare

Aftercare commonly includes avoiding sex, baths and swimming for 24 to 48 hours while injection points settle, plus advice on symptoms to report.

When to reassess

If symptoms continue, worsen or change pattern, the plan should be reviewed rather than assuming repeat PRP is the answer.

Practical expectations

Pricing and treatment plans should be confirmed on the /pricing/ page or with the clinic before booking.

A follow-up discussion is useful if symptoms do not improve, discomfort persists, or the pattern suggests a different underlying cause.





Common concerns and myths

Common misunderstandings

Clear information matters because complex intimate symptoms are often marketed as though one treatment can solve several different problems.

Myth: PGAD is high libido

Reality: PGAD is not the same as desire or arousal. It can be unwanted and distressing, and it needs careful clinical assessment.

Myth: symptoms should be hidden

Reality: intimate symptoms are common enough to discuss and important enough to assess properly.

Myth: no assessment is needed

Reality: symptoms can overlap with infection, skin disease, pelvic-floor pain, nerve symptoms, scarring and menopause-related change.

Evidence and uncertainty

Research into vaginal PRP is growing, but preparation methods, injection protocols and outcome measures vary, so cautious language is important.

Alternatives and combined care

Conservative care, local hormone options, vulval treatment, scar care, pelvic-floor care, pain management or specialist referral may be more appropriate first.





Safety checklist

Safety checklist

Use these questions to decide whether the next step should be consultation, further assessment, treatment planning or urgent advice.

Has the cause been assessed?

Symptoms should be mapped by pattern, medical history, medication, menopause status, surgery or childbirth history and any pain, bleeding or discharge.

Are symptoms stable?

New, severe, worsening or unexplained symptoms should be reviewed before an elective intimate procedure.

Are options clear?

Ask how PRP compares with conservative care, medication, pelvic-floor support, specialist review or other relevant options.

Is follow-up planned?

You should know what to expect, what aftercare to follow, when to seek help and when the response will be reviewed.

Reassuring signs

It is more reasonable to discuss PRP when symptoms have been assessed, red flags are absent, goals are realistic and alternatives have been explained.

Assessed
Realistic goals
Aftercare clear

Reasons to pause

Pause and seek medical review if symptoms include unexplained bleeding, unusual discharge, fever, severe pain, new numbness, vulval lesions or sudden urinary change.

Bleeding
Infection signs
New numbness




When to escalate

When to seek medical help

Some symptoms should be assessed promptly before any elective intimate treatment is considered. Use NHS 111 online

Severe or worsening pain

Seek medical advice if pelvic, vulval or vaginal pain is severe, sudden, worsening or unexplained.

Bleeding or discharge

Unexplained bleeding, bleeding after sex, foul-smelling discharge or unusual discharge should be reviewed before treatment.

Infection signs

Fever, feeling unwell, spreading redness, pus, worsening swelling or urinary infection symptoms need prompt clinical advice.

New numbness or bladder change

Sudden genital numbness, numbness into the legs, new weakness or sudden bladder change should be assessed urgently.

Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.

Next step

Book a clinical consultation

A consultation can confirm whether PRP is worth discussing, whether another pathway should come first, and what realistic outcomes and aftercare would look like.

View Research Sources (12 Sources)
• Position Statement: Global gynaecological health - RCOG
• Position statements | RCOG
• Application of Platelet-Rich Plasma in Gynaecologic Disorders: A Scoping Review - PubMed
• HTG435 Sacrocolpopexy with hysterectomy using mesh to repair uterine prolapse: Overview final - NICE
• National Institute for Health and Care Excellence IP 660/2 Transvaginal mesh repair of anterior or posterior vaginal wall - NICE
• Surgical repair of vaginal wall prolapse using mesh - NICE
• British association for sexual health and HIV national guideline for the management of anogenital warts in adults (2024) - PubMed
• Complex Congenital Gynaecology and Differences of Sex Development : University College London Hospitals NHS Foundation Trust
• Vaginal Injection of Platelet-Rich Plasma for Sexual Function: A randomised Controlled Trial - PubMed
• Curriculum 2024 Guide for Special Interest Training Module (SITM): Urogynaecology and Vaginal Surgery (UGVS) - RCOG
• RCOG responds to Government's Elective Reform Plan
• RCOG strategy 2025–2030

These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 67 imported records. Additional reviewed material included peer-reviewed clinical papers, evidence reviews, clinical trial records; duplicate, low-relevance and non-clinical records were removed before display.

Educational only. This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. The O-Shot is an off-label, investigational PRP procedure in this context, and suitability must be confirmed after individual consultation. Results vary. Not a cure.

Loading directory...